Phibro Animal Health Co. (NASDAQ:PAHC - Free Report) - Research analysts at Zacks Research lifted their FY2025 earnings per share estimates for shares of Phibro Animal Health in a note issued to investors on Wednesday, March 12th. Zacks Research analyst R. Department now forecasts that the company will post earnings per share of $1.91 for the year, up from their prior estimate of $1.87. The consensus estimate for Phibro Animal Health's current full-year earnings is $1.95 per share.
Several other equities analysts have also issued reports on the company. Morgan Stanley raised their price target on Phibro Animal Health from $20.00 to $25.00 and gave the stock an "equal weight" rating in a research report on Tuesday, December 17th. StockNews.com raised Phibro Animal Health from a "hold" rating to a "buy" rating in a research note on Saturday, March 15th. Finally, Barclays raised their price objective on shares of Phibro Animal Health from $20.00 to $22.00 and gave the stock an "underweight" rating in a report on Monday, February 10th. Two equities research analysts have rated the stock with a sell rating, two have given a hold rating and one has issued a buy rating to the company's stock. Based on data from MarketBeat, Phibro Animal Health currently has an average rating of "Hold" and a consensus price target of $21.00.
Read Our Latest Stock Analysis on PAHC
Phibro Animal Health Trading Down 2.1 %
NASDAQ:PAHC traded down $0.48 during trading hours on Monday, reaching $21.81. The company's stock had a trading volume of 69,406 shares, compared to its average volume of 176,180. The firm has a 50-day simple moving average of $22.63 and a 200-day simple moving average of $22.59. Phibro Animal Health has a 1 year low of $12.07 and a 1 year high of $26.55. The firm has a market capitalization of $883.17 million, a price-to-earnings ratio of 45.38, a PEG ratio of 0.45 and a beta of 0.58. The company has a debt-to-equity ratio of 2.99, a quick ratio of 1.37 and a current ratio of 3.20.
Phibro Animal Health (NASDAQ:PAHC - Get Free Report) last posted its quarterly earnings data on Wednesday, February 5th. The company reported $0.54 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.40 by $0.14. Phibro Animal Health had a net margin of 1.75% and a return on equity of 25.35%.
Hedge Funds Weigh In On Phibro Animal Health
Several large investors have recently modified their holdings of the stock. Thrivent Financial for Lutherans lifted its position in Phibro Animal Health by 23.1% in the 3rd quarter. Thrivent Financial for Lutherans now owns 20,791 shares of the company's stock valued at $468,000 after acquiring an additional 3,907 shares in the last quarter. Segall Bryant & Hamill LLC raised its holdings in shares of Phibro Animal Health by 1.7% during the third quarter. Segall Bryant & Hamill LLC now owns 174,569 shares of the company's stock valued at $3,931,000 after purchasing an additional 2,971 shares during the last quarter. Algert Global LLC lifted its position in Phibro Animal Health by 521.1% during the third quarter. Algert Global LLC now owns 71,335 shares of the company's stock valued at $1,606,000 after purchasing an additional 59,850 shares during the period. FMR LLC grew its position in Phibro Animal Health by 22.7% in the 3rd quarter. FMR LLC now owns 39,310 shares of the company's stock worth $885,000 after purchasing an additional 7,270 shares during the period. Finally, Quantbot Technologies LP purchased a new stake in Phibro Animal Health during the 3rd quarter valued at $70,000. Hedge funds and other institutional investors own 99.34% of the company's stock.
Phibro Animal Health Announces Dividend
The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, March 26th. Shareholders of record on Wednesday, March 5th will be paid a dividend of $0.12 per share. This represents a $0.48 dividend on an annualized basis and a yield of 2.20%. The ex-dividend date of this dividend is Wednesday, March 5th. Phibro Animal Health's payout ratio is 100.00%.
About Phibro Animal Health
(
Get Free Report)
Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.
Further Reading
Before you consider Phibro Animal Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Phibro Animal Health wasn't on the list.
While Phibro Animal Health currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
